U.S. markets closed

RAMM Pharma Corp. (RAMMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.05500.0000 (0.00%)
At close: 01:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0550
BidN/A x N/A
AskN/A x N/A
Day's Range0.0550 - 0.0550
52 Week Range0.0550 - 0.7000
Avg. Volume619
Market Cap22.801M
Beta (5Y Monthly)0.34
PE Ratio (TTM)N/A
EPS (TTM)-0.0510
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for RAMMF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Daily – Vickers Top Buyers & Sellers for 09/28/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland

    TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to announce that today it has acquired all of the issued and outstanding shares of HemPoland S.p.a. Z.o.o. (“HemPoland”) from The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) for cash consideration of C$1.2 million. HemPoland is a leading European manufacturer and marketer of premium hemp products. The acquisition by Ramm provides access to

  • GlobeNewswire

    RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

    TORONTO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course issuer bid (the “NCIB”), under which it may purchase up to 5% of the current number of issued and outstanding common shares of the Company (the “Common Shares”). The NCIB may commence on or about August 22, 2022 and shall expire on the 12-month anniversary of the effective date of the NCIB. All Common Shar

  • CNW Group

    IIROC Trade Resumption - RAMM

    Trading resumes in: